Interleukin‐1β posttranslational processing—exploration of P2X7 receptor involvement
- 1 June 2001
- journal article
- Published by Wiley in Drug Development Research
- Vol. 53 (2-3), 83-90
- https://doi.org/10.1002/ddr.1175
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Pharmacological characterization of ATP‐ and LPS‐induced IL‐1β release in human monocytesBritish Journal of Pharmacology, 1999
- Effects of antagonists at the human recombinant P2X7 receptorBritish Journal of Pharmacology, 1998
- The isoquinoline derivative KN‐62 a potent antagonist of the P2Z‐receptor of human lymphocytesBritish Journal of Pharmacology, 1997
- Human Monocyte Interleukin-1β Posttranslational ProcessingPublished by Elsevier ,1996
- Activation of the Native 45-kDa Precursor Form of Interleukin-1-converting EnzymeJournal of Biological Chemistry, 1996
- Use of monoclonal antibodies to study interleukin ‐1β‐converting enzyme expression: only precursor forms are detected in interleukin‐1β‐secreting cellsEuropean Journal of Immunology, 1996
- The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell deathImmunology Today, 1995
- The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role.Journal of Clinical Investigation, 1995
- A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytesNature, 1992
- Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release.Journal of Clinical Investigation, 1990